Class III CE certified
CellularMatrix® tubes allow the preparation of autologous platelet-rich plasma (RegenPRP®) combined with a non-crosslinked hyaluronic acid (HA) in a closed-circuit system.
CellularMatrix® technology combines the complementary clinical effects of RegenPRPand hyaluronic acid (HA), giving better and longer-lasting results in patients with osteoarthritis.1,7,8
Hyaluronic acid is a major component of synovial fluid contributing to joint homeostasis.. Hyaluronic acid improves the activity of several molecules contained in platelet-rich plasma to provide additional benefits to OA patients.1
Both PRP and HA have been extensively used to improve lubrication, modulate inflammation and modify the joint catabolic micro-environment, aiming not only to reduce clinical symptoms, but also to slow down OA progression.6
When PRP and HA are used in combination these effects are enhanced and prolonged. HA creates a bioactive scaffolding in which the platelets progressively release their growth factors. RegenPRP does not negatively affect the mechanical, elastic or viscous properties of HA.1
CM-PRP-HA has an excellent safety profile in clinical practice.1,7,8
The simple, safe and efficient point-of-care preparation of autologous platelet-rich plasma.
~3 ml of PRP combined with 2 ml of HA
> 70 %